KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Gains from Investment Securities (2016 - 2025)

Bausch Health Companies' Gains from Investment Securities history spans 17 years, with the latest figure at $5.0 million for Q3 2025.

  • For Q3 2025, Gains from Investment Securities changed 0.0% year-over-year to $5.0 million; the TTM value through Dec 2025 reached $24.0 million, down 7.69%, while the annual FY2025 figure was $24.0 million, 7.69% down from the prior year.
  • Gains from Investment Securities for Q3 2025 was $5.0 million at Bausch Health Companies, up from $3.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $39.0 million in Q2 2022 and bottomed at -$10.0 million in Q1 2022.
  • The 5-year median for Gains from Investment Securities is $4.0 million (2021), against an average of $8.3 million.
  • The largest annual shift saw Gains from Investment Securities crashed 155.56% in 2022 before it surged 700.0% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $4.0 million in 2021, then crashed by 75.0% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then skyrocketed by 200.0% to $3.0 million in 2024, then surged by 66.67% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Gains from Investment Securities are $5.0 million (Q3 2025), $3.0 million (Q2 2025), and $16.0 million (Q1 2025).